Trial Profile
Multicentre, Double-Blind Study Comparing 0.5mg Dutasteride vs. Placebo Daily in Men Receiving Intermittent Androgen Ablation Therapy for Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 15 Jul 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms AVIAS
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 31 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov record.